Ligand Pharmaceuticals (LGND) EPS (2010 - 2026)
Ligand Pharmaceuticals (LGND) EPS from Jun 30, 2010 to Mar 31, 2026. The TTM Ligand Pharmaceuticals (LGND) EPS is $7.81. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Ligand Pharmaceuticals (LGND) EPS CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | +49.81% |
| 5 Years TTM | +26.59% |
| 10 Years TTM | -4.06% |
Annual EPS change of Ligand Pharmaceuticals (LGND)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.67 | -110.58% |
| 2025 | $6.29 | -3083.77% |
| 2024 | -$0.21 | -107.10% |
| 2023 | $2.97 | -388.06% |
| 2022 | -$1.03 | +219.01% |
| 2021 | -$0.32 | +74.43% |
| 2020 | -$0.19 | -100.50% |
| 2019 | $37.41 | +442.00% |
| 2018 | $6.90 | +1062.11% |
| 2017 | $0.59 | -857.19% |
| 2016 | -$0.08 | -100.68% |
| 2015 | $11.52 | +1776.15% |
| 2014 | $0.61 | +10.06% |
| 2013 | $0.56 | -2339.99% |
| 2012 | -$0.02 | -110.44% |
| 2011 | $0.24 | -145.13% |
| 2010 | -$0.53 | +411.45% |
| 2009 | -$0.10 | N/A |
Comparison Ligand Pharmaceuticals (LGND) five years EPS CAGR with competitors
Ligand Pharmaceuticals (LGND) five years EPS CAGR is 26.59%.